BioSpace News Archive

OCuSOFT Inc., a privately-held eye and skin care company with an established reputation for innovation in eyelid hygiene is pleased to announce the availability of new OCuSOFT® Lid Scrub® Allergy Eyelid Cleanser for allergy conditions in convenient pre-moistened pads.

The National Electrical Manufacturers Association published NEMA SPD 1.1-2019 Part 1—Surge Protective Device Specification Guide for Low-Voltage Power Distribution Systems.

Seattle Tech Giants Microsoft and Amazon Pledge $5 Million Each

At the U.S. Food and Drug Administration, increasing our scientific knowledge and capabilities is a cornerstone to ensuring the safety of the foods that Americans consume.

GasLab.com has launched its new ecommerce portal allowing global customers to search and purchase a variety of sensors and accessories.

EmCyte, is proud to announce that it has received FDA 510(k) clearance for its PureBMC® Supraphysiologic Concentrating System.

The University of Mount Union is proud to announce that its Physical Therapy program has received accreditation from the Commission on Accreditation in Physical Therapy Education.

Results of the PIONEER 6 trial indicate oral semaglutide is safe for patients with type 2 diabetes (T2D) at high cardiovascular (CV) risk, according to results announced at the symposium titled “Oral Semaglutide—The PIONEER Program Trials” today at the American Diabetes Association’s® (ADA) 79th Scientific Sessions® at the Moscone Convention Center in San Francisco.

“Such intriguing questions go to the heart of how we think about the value of individual human beings,” says John G. West, a co-creator of the new Science Uprising video series from Discovery Institute.

The University of Chicago Medicine’s Comprehensive Hypertension Center is participating in an FDA-approved pivotal trial of a novel catheter-based, non-surgical procedure to treat patients with drug-resistant hypertension.